From the aticle in Flaherty Financial Newsletter #46;
'Preliminary human trials for Vantage Health Sensor began in August at the Scripps Translational Science Institute, paid for by a bio pharma partner of the company.'
WOW, COOL! Preliminary human trials for Vantage Health Sensor began in August at the Scripps Translational Science Institute, paid for by a bio pharma partner of the company.